← Open Payments lookup

TINA HAMILTON: Open Payments

NPI 1629076054 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$737 in 23 payments from 8 companies in 2025. Trend: 2023 $133 · 2024 $447 · 2025 $737

Food & beverage: $737
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.11$354
AstraZeneca Pharmaceuticals LP3$151
Bayer Healthcare Pharmaceuticals Inc.3$65
Novo Nordisk Inc2$50
Calliditas Therapeutics US Inc.1$33
Vifor Pharma, Inc.1$33
Lilly USA, LLC1$31
Novartis Pharmaceuticals Corporation1$20

Products named: JARDIANCE, LOKELMA, Kerendia, Ozempic, TARPEYO, Veltassa, FARXIGA.

Industry payments across MD — which companies pay providers there.